Adusumilli A.N., Dammalapati S., Fu P.K.-L.
Governors State University, US
Keywords: bone grafting, controlled release, cranial transplantation
The objective of this research is to develop a unique nanoparticulate system that is capable of delivering antibiotics in a locally applied and extended-release manner for patients receiving cranial replacement implants and bone grafting. This study involves three major components: first, encapsulate both hydrophobic antibiotics and hydrophilic antibiotics into nanoparticles. Second, incorporate antibiotic nanoparticles in a polymeric coating material (nitrocellulose plus 7.0% (w/v) polyvinylpyrrolidone) with a volatile carrier solvent such as ethyl acetate. Third, directly apply the resulting product from component 1 and 2 to polymethyl methacrylate (PMMA) cranial implants and hydroxylapatite (HA) bone grafting materials directly before surgery. When the volatile carrier solvent evaporates, the coating polymer with embedded antibiotic nanoparticles will form a thin film that is capably attached to the surface of the implant material. Local application of encapsulated antibiotics directly to the surgical sites can provide a non-oral, non-intravenous, controlled time-release treatment, which would allow continuous administration of antibiotic therapy over the prescribed time span of the individual antibiotics used. Our study provides a novel chemotherapeutic regime for the prevention and treatment of bacterial, fungal, and viral infections often occurred in cranial/bone transplant patients with a more efficient effective dose.
Journal: TechConnect Briefs
Volume: 3, Nanotechnology 2012: Bio Sensors, Instruments, Medical, Environment and Energy (Volume 3)
Published: June 18, 2012
Pages: 150 - 153
Industry sectors: Advanced Materials & Manufacturing | Medical & Biotech
Topics: Biomaterials, Materials for Drug & Gene Delivery
ISBN: 978-1-4665-6276-9